Efficient prophylaxis with defibrotide for hepatic veno-occlusive disease (VOD) after allogeneic stem cell transplantation (SCT).

被引：0
|
作者：
Chalandon, Y
Roosnek, E
Helg, C
Newton, A
Wacker, P
Chapuis, B
机构：
[1] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland
[2] Univ Hosp Geneva, Div Immunol, Geneva, Switzerland
[3] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
411
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [31] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
    Ho, V. T.
    Revta, C.
    Richardson, P. G.
    BONE MARROW TRANSPLANTATION, 2008, 41 (03) : 229 - 237
  • [32] Defibrotide in the treatment of hepatic veno-occlusive disease
    Fulgenzi, Alessandro
    Ferrero, Maria Elena
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 105 - 113
  • [33] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    HAEMATOLOGICA, 2017, 102 : 623 - 623
  • [34] Defibrotide as treatment for hepatic veno-occlusive disease
    Linker, C
    BLOOD, 2002, 100 (13) : 4255 - 4256
  • [35] Hepatic veno-occlusive disease after hemopoietic stem cell transplantation.
    Da, WM
    Zhong, JT
    Liu, Y
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 595 - 595
  • [36] Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Mahadeo, Kris M.
    Bajwa, Rajinder P. S.
    JOURNAL OF PEDIATRIC INTENSIVE CARE, 2014, 3 (03) : 183 - 193
  • [37] Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience
    Antmen, B. A.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    Ucar, G.
    Baysal, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5580 - 5580
  • [38] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Kilicdag, H.
    Karabacak, B.
    Ariker, S.
    Ozturk, S.
    Ucar, G.
    Aslan, N. Aldirmaz
    Ayberkin, B.
    Kilinc, I.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S500 - S500
  • [39] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
    V T Ho
    C Revta
    P G Richardson
    Bone Marrow Transplantation, 2008, 41 : 229 - 237
  • [40] Low-dose defibrotide after allogeneic stem cell transplantation as prophylaxis of veno-occlusive disease of the liver. A single-centre experience
    Bonini, A.
    Tieghi, A.
    Pilia, A.
    Gugliotta, L.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S419 - S419
12345